U.S. markets open in 2 hours 33 minutes
  • S&P Futures

    4,260.50
    +4.50 (+0.11%)
     
  • Dow Futures

    34,186.00
    +104.00 (+0.31%)
     
  • Nasdaq Futures

    14,379.00
    +24.75 (+0.17%)
     
  • Russell 2000 Futures

    2,334.50
    +3.30 (+0.14%)
     
  • Crude Oil

    73.06
    -0.24 (-0.33%)
     
  • Gold

    1,783.00
    +6.30 (+0.35%)
     
  • Silver

    26.25
    +0.20 (+0.79%)
     
  • EUR/USD

    1.1949
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    16.02
    -0.30 (-1.84%)
     
  • GBP/USD

    1.3909
    -0.0012 (-0.09%)
     
  • USD/JPY

    110.7600
    -0.0750 (-0.07%)
     
  • BTC-USD

    33,690.98
    +463.77 (+1.40%)
     
  • CMC Crypto 200

    804.26
    +17.64 (+2.24%)
     
  • FTSE 100

    7,117.23
    +7.26 (+0.10%)
     
  • Nikkei 225

    29,066.18
    +190.95 (+0.66%)
     

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Conference Call to be Held on May 13, 2021

RANCHO CORDOVA, Calif., May 6, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2021 and provide a corporate strategic update on Thursday, May 13, 2021, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.

A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at www.thermogenesis.com.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-first-quarter-ended-march-31-2021-and-provide-a-corporate-strategic-update-301285470.html

SOURCE ThermoGenesis Holdings, Inc.